You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dendritic Cell/AML vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • AML
  • DC AML Vaccine
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 25, 2022

Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
Apr 14, 2022

Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)

Recruiting
  • Acute Myelogenous Leukemia
  • Boston, Massachusetts
  • +1 more
Nov 15, 2021

Acute Myeloid Leukemia Trial in Beijing (DC vaccine)

Recruiting
  • Acute Myeloid Leukemia
  • DC vaccine
  • Beijing, Beijing, China
    Department of hematology
Aug 16, 2021

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

Recruiting
  • Leptomeningeal Disease
  • +2 more
  • Dendritic Cell Vaccine
  • Tampa, Florida
    Moffitt Cancer Center
Apr 11, 2023

Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Mature dendritic cell (DC) vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 2, 2023

Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

Active, not recruiting
Has Results
  • Renal Cancer
  • Dendritic Cell Tumor Fusion Vaccine
  • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 2, 2023

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

Not yet recruiting
  • Cytomegaloviral Infection
  • Hematopoietic and Lymphoid System Neoplasm
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 16, 2022

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

Completed
  • Malignant Glioma
  • +3 more
  • Dendritic Cell Vaccine
  • +3 more
  • Miami, Florida
    University of Miami
Jul 19, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

Completed
Has Results
  • Breast Neoplasms
  • +3 more
  • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022

Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

Recruiting
  • Breast Cancer
  • +7 more
  • Dendritic Cell Vaccine (DC1)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Los Angeles (Autologous

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
  • Pembrolizumab
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022

Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)

Not yet recruiting
  • Postoperative Prevention of Tumor
  • Oral NMN combined with DC cell vaccine
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Sep 6, 2023

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

Active, not recruiting
  • Multiple Myeloma
  • CT-011
  • Dendritic Cell Fusion Vaccine
  • Boston, Massachusetts
  • +2 more
Sep 5, 2022

Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +9 more
  • Cryosurgery
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022